Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib

被引：0
|
作者：
Audrey M. Sigmund
Ying Huang
Amy S. Ruppert
Kami Maddocks
Kerry A. Rogers
Samantha Jaglowski
Seema A. Bhat
Adam S. Kittai
Michael R. Grever
John C. Byrd
Jennifer A. Woyach
机构：
[1] The Ohio State University,Division of Hematology
[2] The University of Cincinnati,Department of Internal Medicine
来源：
Leukemia | 2022年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2129 / 2131
页数：2
相关论文
共 50 条
  • [1] Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib
    Sigmund, Audrey M.
    Huang, Ying
    Ruppert, Amy S.
    Maddocks, Kami
    Rogers, Kerry A.
    Jaglowski, Samantha
    Bhat, Seema A.
    Kittai, Adam S.
    Grever, Michael R.
    Byrd, John C.
    Woyach, Jennifer A.
    [J]. LEUKEMIA, 2022, 36 (08) : 2129 - 2131
  • [2] Depth of Response and Progression-Free Survival in CLL Patients on Ibrutinib
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (07) : 8 - 9
  • [3] Complete Response Linked to Progression-Free Survival in Chronic Lymphocytic Leukemia
    Schuyler, Devon
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 92 - 92
  • [4] The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Amit Mahipal
    Mark Weiss
    [J]. Current Oncology Reports, 2010, 12 : 352 - 354
  • [5] The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Mahipal, Amit
    Weiss, Mark
    [J]. CURRENT ONCOLOGY REPORTS, 2010, 12 (06) : 352 - 354
  • [6] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Beauchemin, C.
    Johnston, J.
    Lapierre, M. E.
    Aissa, F.
    Lachaine, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A414 - A415
  • [7] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Beauchemin, C.
    Johnston, J. B.
    Lapierre, M.
    Aissa, F.
    Lachaine, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 350 - 350
  • [8] Response, Progression-Free Survival, and Overall Survival of patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Treated with Flavopiridol: Impact of Poor Risk Cytogenetic Abnormalities
    Woyach, Jennifer A.
    Ruppert, Amy S.
    Blum, Kristie A.
    Jones, Jeffrey Alan
    Flynn, Joseph M.
    Johnson, Amy J.
    Grever, Michael R.
    Byrd, John C.
    Heerema, Nyla A.
    [J]. BLOOD, 2010, 116 (21) : 1019 - 1020
  • [9] Depth of response and progression free survival in CLL patients on ibrutinib.
    Sigmund, Audrey
    Huang, Ying
    Ruppert, Amy S.
    Ny, Fan
    Lucas, Margaret
    Chase, Weihong
    Maddocks, Kami J.
    Rogers, Kerry Anne
    Jaglowski, Samantha Mary
    Andritsos, Leslie Ann
    Awan, Farrukh Tauseef
    Grever, Michael R.
    Byrd, John C.
    Woyach, Jennifer Ann
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab
    Awan, Farrukh T.
    Kay, Neil E.
    Davis, Melanie E.
    Wu, Wenting
    Geyer, Susan M.
    Leung, Nelson
    Jelinek, Diane F.
    Tschumper, Renee C.
    Secreto, Charla R.
    Lin, Thomas S.
    Grever, Michael R.
    Shanafelt, Tait D.
    Zent, Clive S.
    Call, Timothy G.
    Heerema, Nyla A.
    Lozanski, Gerard
    Byrd, John C.
    Lucas, David M.
    [J]. BLOOD, 2009, 113 (03) : 535 - 537
12345